Francesco Malvestiti

Carriage of rare APOB variants predisposes to severe steatotic liver disease and hepatocellular carcinoma

Genome-wide interaction study with body mass index identifies <i>CYP7A1</i> and <i>GIPR</i> as genetic modulators of metabolic dysfunction-associated steatotic liver disease

Germline Variants Influence Chronic Liver Disease Progression through Distinct Pathways

Publisher Correction: Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease

Genome-wide association study of noninvasive scores of fibrotic MASLD in an Italian population

Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease

Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease

IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids

Author Correction: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women

Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease

Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women

Predictors of controlled attenuation parameter in metabolic dysfunction

Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease

Rare ATG7 genetic variants predispose patients to severe fatty liver disease

Increased burden of inherited IRF3 rare genetic variants in Europeans with severe NAFLD

Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease

OC-08Rare ATG7 genetic variants predispose to severe fatty liver disease